3D s. Delerium Dementia Depression
|
|
- Gwenda Page
- 5 years ago
- Views:
Transcription
1 3D s Delerium Dementia Depression Greg Thomson M.D. Family Physician Medical Program Lead Rehabilitation and Geriatrics Halton Healthcare August 2017 Collaboration with Dr. T. Bibic
2 Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted in any form or by any means graphic, electronic, or mechanical, including photocopying, recording, or information storage and retrieval systems without prior written permission of Sea Courses Inc. except where permitted by law. Sea Courses is not responsible for any speaker or participant s statements, materials, acts or omissions.
3 Faculty/Presenter Disclosure Faculty: Dr. Greg Thomson Relationships with commercial interests: Moderator /Honoraria: - Janssen Canada - Astella Pharma - Amgen Canada
4 Disclosure of Commercial Support This program has not received financial support in the form of an educational grant Speaker will receive an honoraria from Sea Courses for these talks
5 Mitigating Potential Bias Dr. Greg Thomson This talk will review multiple geriatric and family medicine conditions and and will not focus on treatments beyond class effects. Information/recommendations in the program are evidence- and/or guidelines-based; opinions of the presenter will be identified as such. The Speaker completed the CPFC Mainpro+ Declaration of Conflict of Interest form evidencing compliance with Mainpro+ requirements
6 objectives Review Delirium Review Dementia Review Depression Distinguish between 3D s Inter-relationship amongst them
7 depression delirium dementia
8 DELIRIUM
9 Setting Incidence of Delirium Emergency Department 33% General Medicine Service 11-42% Admission to ICU 72% After cardiac surgery or stroke 25% Discharged to Community 1-2% Discharged to Skilled Nursing Facility 16% End-of-life Delirium 85%
10 Forms of Delirium Hyperactive only 25% of cases Hypoactive apathy, slowness of movement, staring, decreased alertness quiet delirium is most common, often confused with adjustment/depressive symptoms, associated with poorer prognosis. Delirium with mixed features
11 Baseline or Predisposing Factors Advanced Age 1/3 of over 70y.o. Cognitive impairment Visual impairment Impairment in ADLs High medical comorbidity burden Also: male, hearing loss, depression, alcohol abuse Acute or Precipitating Factors Drugs Electrolyte disturbances Lack of drugs Infection Reduced sensory Intracranial Urinary/fecal Myocardial/pulmonary JGIM 1998 March; 13: 204
12 Beers List AGS 2015 Beers Criteria for Potentially Inappropriate Medication Use in Older Adults
13 ACB Scale Anticholinergic Cognitive Burden Drugs with ACB Score of 1 Generic Name Brand Name Alimemazine Theralen Alverine Spasmonal Alprazolam Xanax Aripiprazole Abilify Asenapine Saphris Atenolol Tenormin Bupropion Wellbutrin, Zyban Captopril Capoten Cetirizine Zyrtec Chlorthalidone Diuril, Hygroton Cimetidine Tagamet Clidinium Librax Clorazepate Tranxene Codeine Contin Colchicine Colcrys Desloratadine Clarinex Diazepam Valium Digoxin Lanoxin Dipyridamole Persantine Disopyramide Norpace Fentanyl Duragesic, Actiq Furosemide Lasix Fluvoxamine Luvox Haloperidol Haldol Hydralazine Apresoline Hydrocortisone Cortef, Cortaid Iloperidone Fanapt Isosorbide Isordil, Ismo Levocetirizine Xyzal Loperamide Immodium, others Loratadine Claritin Metoprolol Lopressor, Toprol Morphine MS Contin, Avinza Nifedipine Procardia, Adalat Paliperidone Invega Prednisone Deltasone, Sterapred Quinidine Quinaglute Ranitidine Zantac Risperidone Risperdal Theophylline Theodur, Uniphyl Trazodone Desyrel Triamterene Dyrenium Venlafaxine Effexor Warfarin Coumadin Generic Name Amantadine Belladonna Carbamazepine Cyclobenzaprine Cyproheptadine Loxapine Meperidine Methotrimeprazine Molindone Nefopam Oxcarbazepine Pimozide Drugs with ACB Score of 2 Brand Name Symmetrel Multiple Tegretol Flexeril Periactin Loxitane Demerol Levoprome Moban Nefogesic Trileptal Orap Categorical Scoring: Possible anticholinergics include those listed with a score of 1; Definite anticholinergics include those listed with a score of 2 or 3 Numerical Scoring: Add the score contributed to each selected medication in each scoring category Add the number of possible or definite Anticholinergic medications Notes: Each definite anticholinergic may increase the risk of cognitive impairment by 46% over 6 years. 3 For each on point increase in the ACB total score, a decline in MMSE score of 0.33 points over 2 years has been suggested. 4 Additionally, each one point increase in the ACB total score has been correlated with a 26% increase in the risk of death. 4 Aging Brain Care Drugs with ACB Score of 3 Generic Name Brand Name Amitriptyline Elavil Amoxapine Asendin Atropine Sal-Tropine Benztropine Cogentin Brompheniramine Dimetapp Carbinoxamine Histex, Carbihist Chlorpheniramine Chlor-Trimeton Chlorpromazine Thorazine Clemastine Tavist Clomipramine Anafranil Clozapine Clozaril Darifenacin Enablex Desipramine Norpramin Dicyclomine Bentyl Dimenhydrinate Dramamine, others Diphenhydramine Benadryl, others Doxepin Sinequan Doxylamine Unisom, others Fesoterodine Toviaz Flavoxate Urispas Hydroxyzine Atarax, Vistaril Hyoscyamine Anaspaz, Levsin Imipramine Tofranil Meclizine Antivert Methocarbamol Robaxin Nortriptyline Pamelor Olanzapine Zyprexa Orphenadrine Norflex Oxybutynin Ditropan Paroxetine Paxil Perphenazine Trilafon Promethazine Phenergan Propantheline Pro-Banthine Propiverine Detrunorm Quetiapine Seroquel Scopolamine Transderm Scop Solifenacin Vesicare Thioridazine Mellaril Tolterodine Detrol Trifluoperazine Stelazine Trihexyphenidyl Artane Trimipramine Surmontil Trospium Sanctura Drugs with ACB Score of 1 Generic Name Brand Name Alimemazine Theralen Alverine Spasmonal Alprazolam Xanax Aripiprazole Abilify Asenapine Saphris Atenolol Tenormin Bupropion Wellbutrin, Zyban Captopril Capoten Cetirizine Zyrtec Chlorthalidone Diuril, Hygroton Cimetidine Tagamet Clidinium Librax Clorazepate Tranxene Codeine Contin Colchicine Colcrys Desloratadine Clarinex Diazepam Valium Digoxin Lanoxin Dipyridamole Persantine Disopyramide Norpace Fentanyl Duragesic, Actiq Furosemide Lasix Fluvoxamine Luvox Haloperidol Haldol Hydralazine Apresoline Hydrocortisone Cortef, Cortaid Iloperidone Fanapt Isosorbide Isordil, Ismo Levocetirizine Xyzal Loperamide Immodium, others Loratadine Claritin Metoprolol Lopressor, Toprol Morphine MS Contin, Avinza Nifedipine Procardia, Adalat Paliperidone Invega Prednisone Deltasone, Sterapred Quinidine Quinaglute Ranitidine Zantac Risperidone Risperdal Theophylline Theodur, Uniphyl Trazodone Desyrel Triamterene Dyrenium Venlafaxine Effexor Warfarin Coumadin Generic Name Amantadine Belladonna Carbamazepine Cyclobenzaprine Cyproheptadine Loxapine Meperidine Methotrimeprazine Molindone Nefopam Oxcarbazepine Pimozide Drugs with ACB Score of 2 Brand Name Symmetrel Multiple Tegretol Flexeril Periactin Loxitane Demerol Levoprome Moban Nefogesic Trileptal Orap Categorical Scoring: Possible anticholinergics include those listed with a score of 1; Definite anticholinergics include those listed with a score of 2 or 3 Numerical Scoring: Add the score contributed to each selected medication in each scoring category Add the number of possible or definite Anticholinergic medications Notes: Each definite anticholinergic may increase the risk of cognitive impairment by 46% over 6 years. 3 For each on point increase in the ACB total score, a decline in MMSE score of 0.33 points over 2 years has been suggested. 4 Additionally, each one point increase in the ACB total score has been correlated with a 26% increase in the risk of death. 4 Aging Brain Care Drugs with ACB Score of 3 Generic Name Brand Name Amitriptyline Elavil Amoxapine Asendin Atropine Sal-Tropine Benztropine Cogentin Brompheniramine Dimetapp Carbinoxamine Histex, Carbihist Chlorpheniramine Chlor-Trimeton Chlorpromazine Thorazine Clemastine Tavist Clomipramine Anafranil Clozapine Clozaril Darifenacin Enablex Desipramine Norpramin Dicyclomine Bentyl Dimenhydrinate Dramamine, others Diphenhydramine Benadryl, others Doxepin Sinequan Doxylamine Unisom, others Fesoterodine Toviaz Flavoxate Urispas Hydroxyzine Atarax, Vistaril Hyoscyamine Anaspaz, Levsin Imipramine Tofranil Meclizine Antivert Methocarbamol Robaxin Nortriptyline Pamelor Olanzapine Zyprexa Orphenadrine Norflex Oxybutynin Ditropan Paroxetine Paxil Perphenazine Trilafon Promethazine Phenergan Propantheline Pro-Banthine Propiverine Detrunorm Quetiapine Seroquel Scopolamine Transderm Scop Solifenacin Vesicare Thioridazine Mellaril Tolterodine Detrol Trifluoperazine Stelazine Trihexyphenidyl Artane Trimipramine Surmontil Trospium Sanctura
14 For prevention of delirium: only non-pharmacologic interventions HELP program Evidence shows no significant difference in prophylaxis with pharmaceutical agents.
15 PREVENTABLE IN 30% OF CASES Cognitive Stimulation Sleep hygiene* Mobilize Address visual and hearing impediments Volume repletion NEJM 1999 March; 340(9): 669
16 Treatment with Antipsychotics may be warranted for severe agitation endangering patient safety for psychotic symptoms, such as hallucinations or delusions, causing severe distress. prescribed in the lowest effective dose for the shortest possible duration, generally less than 1-2 days. should always be revaluated regularly, especially with transition of care.
17 Antipsychotic Medication for Prevention and Treatment of Delirium in Hospitalized Adults: A Systematic Review and Meta- Analysis Conclusion: Current evidence does not support the use of antipsychotics for prevention or treatment of delirium. Additional methodologically rigorous studies using standardized outcome measures are needed JAGS 64: , 2016
18 Adverse Outcome after Hospitalization and Delirium in person with AD There is increased risk of: death cognitive decline institutionalization AIM 2012
19 Witlox, J. (2012). Delirium in the elderly: biomarkers and outcomes
20 DEMENTIA
21
22 As of 2016 there were an estimated 564,000 Canadians living with dementia 25,000 new cases expected each year By 2031 expect 937,000 Canadians will have dementia From Alzheimer s Society Canada February 2017
23
24 neurocognitive disorder Dementia has been renamed by DMS-V: 'major neurocognitive disorder' 'mild neurocognitive disorder'.
25 Diagnostic criteria for Mild Neurocognitive disorder = MCI Evidence of modest cognitive decline from a previous level of performance based on the cognitive deficits that do not interfere with capacity for independence in everyday activities but greater effort, compensatory strategies, or accommodation may be required DSM 5, 2013
26 Dementia = Major Neurocognitive Disorder Criteria A. Evidence of significant cognitive decline from a previous level of performance in one or more cognitive domains: - Learning and memory - Language - Executive function - Complex attention - Perceptual-motor - Social cognition * Evidence of decline is based on: Concern of the individual, a knowledgeable informant, or the clinician that there has been a significant decline in cognitive function; and a substantial impairment in cognitive performance, preferably documented by standardized neuropsychological testing or, in its absence, another quantified clinical assessment. B. The cognitive deficits interfere with independence in everyday activities. At a minimum, assistance should be required with complex instrumental activities of daily living, such as paying bills or managing medications C. The cognitive deficits do not occur exclusively in the context of a delirium D. The cognitive deficits are not better explained by another mental disorder (eg, major depressive disorder, schizophrenia) DSM 5, 2013
27 Risk factors Age Family History and Genetics Severe or repeated head injury Vascular Disease Certain Brain infections Smoking Hypertension Poor diet (lack of Vit D) Lack of physical activity COMMON SIGNS Frequent forgetfulness, especially of recent events Difficulty with common tasks Forgetting common words Becoming lost in familiar areas Poor judgement Changes in mood, behaviour or personality Lack of interest or involvement in life activities
28 Treatment modalities Pharmacological: Acetylcholinesterase Enzyme Inhibitors NMDA Receptor Inhibitor CVD/Risk Factors Medication optimization Non-Pharmacological: Ensure Supports Increased brain stimulatory activity Exercise and good nutrition Monitor for Caregiver Burnout
29 Depression
30 Depression in older adults A significant public health problem for older adults Under-recognized Undertreated May not meet strict diagnostic criteria Symptoms overlap with those of dementia Treatable If missed potentially life threatening
31 SIGECAPS A. Five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure: Sleep disorder (increase or decrease) Interest deficit (anhedonia) Guilt (worthless, hopeless, regret) Energy deficit (fatigue) Concentration deficit Appetite disorder (decrease or increase) Psychomotor retardation or agitation Suicidal ideation B. The symptoms cause clinically significant distress or impairment in social, occupational, or other important areas of functioning. C. The episode is not attributable to the physiological effects of a substance or to another medical condition. DSM 5, 2013
32 RISK FACTORS A prior episode of major depression Severe psychosocial events (stressors), such as death of a loved one, marital separation, divorce Chronic general medical conditions Substance dependence issues A family history of depressive disorders Being female Loss of independent functioning Acutely disabling conditions (e.g., stroke, MI) Physical disability
33 There is reciprocal interaction between depression and frailty in older adults. Specifically, each condition is associated with an increased prevalence and incidence of the other, and may be a risk factor for the development of the other. P. Soysal et al., Ageing Research Reviews 36 (2017) 78 Low HDL cholesterol and high triglyceride levels are associated with lower likelihood of long-term symptom resolution in depression. Virtanen, M., et. Al. J Clin Psychiatry, 78 (1) e1 Insomnia leads to more severe depression, as well as associated poor verbal fluency and poor memory. Virtanen, M. et. Al. J Clin Psychiatry, 78 (1) e1january 2017
34
35 SCREENING TOOLS Requires administration of Mini-Mental State Examination, and Geriatric Depression Scale Short Form or Cornell Scale for Depression in Dementia, depending on level of cognitive functioning. Journal of Gerontological Nursing 2015: 41(11), 15.
36 Geriatric Depression Scale (Short Form) Patient s Name: Date: Instructions: Choose the best answer for how you felt over the past week. No. Question Answer Score 1. Are you basically satisfied with your life? YES / NO 2. Have you dropped many of your activities and interests? YES / NO 3. Do you feel that your life is empty? YES / NO 4. Do you often get bored? YES / NO 5. Are you in good spirits most of the time? YES / NO 6. Are you afraid that something bad is going to happen to you? YES / NO 7. Do you feel happy most of the time? YES / NO 8. Do you often feel helpless? YES / NO 9. Do you prefer to stay at home, rather than going out and doing new things? YES / NO 10. Do you feel you have more problems with memory than most? YES / NO 11. Do you think it is wonderful to be alive? YES / NO 12. Do you feel pretty worthless the way you are now? YES / NO 13. Do you feel full of energy? YES / NO 14. Do you feel that your situation is hopeless? YES / NO 15. Do you think that most people are better off than you are? YES / NO TOTAL Scoring: Assign one point for each of these answers: 1. NO 4. YES 7. NO 10. YES 13. NO 2. YES 5. NO 8. YES 11. NO 14. YES 3. YES 6. YES 9. YES 12. YES 15. YES A score of 0 to 5 is normal. A score above 5 suggests depression. Source: Yesavage J.A., Brink T.L., Rose T.L. et al. Development and validation of a geriatric depression screening scale: a preliminary report. J. Psychiatr. Res. 1983; 17:37-49.
37 SCREENING The AGS recommends depression screening two to four weeks after admission to a nursing home and then repeated screening at least every six months after admission. GDS score 5 may indicate possible depressive episode CSDD score 11 may indicate possible depressive episode
38 Apart from pharmacotherapy
39 Effect of Collaborative Care vs Usual Care on Depressive Symptoms in Older Adults With Subthreshold Depression: The CASPER Randomized Clinical Trial Collaborative care was coordinated by a case manager who assessed functional impairments relating to mood symptoms. Participants were offered behavioral activation and completed an average of 6 weekly sessions. Among older adults with subthreshold depression, collaborative care compared with usual care resulted in a statistically significant difference in depressive symptoms at 4-month follow-up, of uncertain clinical importance. JAMA. 2017;317(7 ):728
40 Am J of Geri Psych 2016 Jan;24(1):11 Problem-Solving Therapy Reduces Suicidal Ideation In Depressed Older Adults with Executive Dysfunction. PST is a promising intervention for older adults who are at risk for suicide.
41 Mirza SS, et. Al. Lancet Psychiatry 2016 Benefits of early treatment Early onset of treatment of depression has effect on future cognitive decline. Depression increases risk of dementia.
42 QUESTIONS?
Onset Acute or sub-acute Insidious. Fluctuating, usually resolves over Progressive
Guideline Name: Delirium Delirium is an acute confusional state characterised by a global disturbance in cerebral function affecting consciousness, attention, cognition and perception with a course that
More informationSupplementary Online Content
Supplementary Online Content Risacher SL, McDonald BC, Tallman EF, et al; Alzheimer s Disease Neuroimaging Initiative. Association between anticholinergic medication use and cognition, brain metabolism,
More informationPharmacy Drug Class Review
Pharmacy Drug Class Review April 15, 2014 Authored By: Gina DeRue PharmD, CDE, BCACP Disclaimer: Specific agents may have variations Edited By: Richard J. Kraft, Pharm.D.BCPS ANTICHOLINERGIC BURDEN A focus
More informationMedications and Children Disorders
Mental Health Comprehensive Services Providing Family Stability and Developing Life Coping Skills Medications and Children Disorders Psychiatric medications can be an effective part of the treatment for
More informationHave You Ever Wondered
Have You Ever Wondered A few facts about medication use and related falls The Number of Medications You Take & The Connection to Falls CONCERN: As you increase the number of medications that you take,
More informationAppendix: Psychotropic Medication Reference Tables
Appendix: Psychotropic Medication Reference Tables How to Use these Tables These reference tables are designed to provide clinic staff with specific medication related criteria for the Polypharmacy, Cardiometabolic
More informationSupplementary Online Content
Supplementary Online Content Gray SL, Anderson ML, Dublin S, et al. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med. Published online January
More informationDealing with a Mental Health Crisis
Dealing with a Mental Health Crisis Information and Resources for First Responders P... PROFESSIONAL WHAT NAMI DOES NAMI Minnesota is a statewide 501(c)(3) grassroots nonprofit organization dedicated to
More informationMay 22, DAL: DAL SUBJECT: Hot Weather Advisory. Dear Administrator/Operator:
May 22, 2013 DAL: DAL 13-11 SUBJECT: Hot Weather Advisory Dear Administrator/Operator: The New York State Department of Health would like to remind you of our expectations regarding the protection of Adult
More informationReview of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)
Review of Psychotrophic Medications (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Common Psychiatric Disorders *Schizophrenia *Depression *Bipolar Disorder
More informationSteps for Initiating Electroconvulsive Therapy Treatment
Steps for Initiating Electroconvulsive Therapy Treatment PSYCHIATRISTS CAN REFER PATIENTS FOR ECT TREATMENT AT EL CAMINO HOSPITAL BY CALLING THE ECT NURSE COORDINATOR AT 650-962-5795. Once the referral
More informationMO Medicaid Foster Care Drugs FY10-FY14
MO Medicaid Foster Care Drugs FY10-FY14 Medicaid (MO HealthNet) Cost of Drugs given to Missouri Foster Care Children by combinations of Age, Gender, Drug Class and Fiscal Year [Raw Data Provided by Missouri
More informationPennsylvania Academy of Family Physicians Foundation & UPMC 43rd Refresher Course in Family Medicine CME Conference March 10-13, 2016
Pennsylvania Academy of Family Physicians Foundation & UPMC 43rd Refresher Course in Family Medicine CME Conference March 10-13, 2016 Disclosures: Drugs in Older Adults: Beers Criteria Heather Sakely,
More informationObjectives. Antipsychotics 7/25/2016. LeadingAge Florida 53rd Annual Convention & Exposition
Reducing the Use of Antipsychotics in Long Term Care Communities Alan W. Obringer RPh, CPh, CGP Executive Director Senior Care Pharmacy Objectives Recognize the clinical evidence for the need to change
More informationIMPORTANT NOTICE. Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members
IMPORTANT NOTICE Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members These changes apply only to members covered under the DC Healthcare Alliance program Alliance
More informationTRANSCRANIAL MAGNETIC STIMULATION & BRAIN MUSIC THERAPY
TMS - DEPRESSION HISTORY Date: Patient Name: DOB: How did you hear about TMS? What do you know about TMS? Referring Physician? Name of Practice: Name of Inpatient Treatment for Depression: Name of Inpatient
More informationJudges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children
Judges Reference Table for the Psychotropic Medication Utilization Parameters for Foster Children Stimulants for treatment of ADHD Preschool (Ages 3-5 years) Child (Ages 6-12 years) Adolescent (Ages 13-17
More informationHow did we get here? 1876 Methylene Blue. Insecticide 1935 Du Pont Anthelmintic. Garrett McCann, RPh
Polypharmacy, Adverse Effects, and the Importance of Tapering Medications for People with Intellectual and Developmental Disabilities Garrett McCann, RPh How did we get here? 1876 Methylene Blue Insecticide
More informationOverview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials
SPEAKER NOTES Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials Summarized by Thomas T. Thomas New psychotropic medications are coming on the
More informationPSYCHIATRY INTAKE FORM
Please complete all information on this form. PSYCHIATRY INTAKE FORM Name Date Date of Birth Primary Care Physician Current Therapist/Counselor What are the problem(s) for which you are seeking help? 1.
More informationPsychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA
Psychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA Goals of Medications Use least number at lowest dose to get
More informationStudy Guidelines for Quiz #1
Annex to Section J Page 1 Study Guidelines for Quiz #1 Theory and Principles of Psychopharmacology, Classifications and Neurotransmitters, Anxiolytics/Antianxiety/Minor Tranquilizers, Stimulants, Nursing
More informationHappy Daisy Ltd. New Client intake Form. What are the issues for which you are seeking care?
Happy Daisy Ltd. New Client intake Form Name Date Preferred name Pronouns Referred by Date of birth Age Race What are the issues for which you are seeking care? 1. 2. 3. Please check of any of the symptoms
More informationGuide to Psychiatric Medications for Children and Adolescents
Guide to Psychiatric Medications for Children and Adolescents by Glenn S. Hirsch, M.D. The following guide includes most of the medications used to treat child and adolescent mental disorders. It lists
More informationMental Health: Subjective evaluation of overall quality of life (QOL) Happiness, life satisfaction, morale, trait effect, etc. Quality of Life (QOL)
Mental Health: Subjective evaluation of overall quality of life (QOL) Happiness, life satisfaction, morale, trait effect, etc. Quality of Life (QOL) Multidimensional concept Includes: Physical health Cognitive
More informationHCA BHS Prescribing Guidelines Committee - Approved Medications 2012
Amitriptyline/Perphenazine Triavil MAJOR TRANQUILIZERS Beneficiaries 10/2, 10/4, 25/2, 25/4, 50/4 Aripiprazole Abilify 2mg, 5mg, 10mg, 15mg, 20mg, 30mg Quantity Limit 31 / mo for Asenapine Saphris 5mg,
More informationAllergy: Levocetirizine (Xyzal) (F) Desloratadine (Clarinex) (NF) OTC Cetirizine (Zyrtec) (NF) OTC Loratadine (Claritin) (NF) Dexchlorpheniramine
Anticholinergics Brompheniramine Carbinoxamine Chlorpheniramine Clemastine Cyproheptadine Highly anticholinergic, clearance reduced with advanced age, and tolerance develops when used as hypnotic; greater
More informationDual Diagnosis: Substance Abuse and Mental Illness
Dual Diagnosis: Substance Abuse and Mental Illness and a review of the major PSYCHIATRIC MEDICINES Mark Stanford, Ph.D. Santa Clara Valley Health & Hospital System Department of Alcohol & Drug Services
More informationDepression. University of Illinois at Chicago College of Nursing
Depression University of Illinois at Chicago College of Nursing 1 Learning Objectives Upon completion of this session, participants will be better able to: 1. Recognize depression, its symptoms and behaviors
More informationRichard Heidenfelder M.D. Child, Adolescent and Adult Psychiatry 447 9th Ave San Diego, CA
*We are not accepting any New Patients who are currently taking any controlled pain medications *We are *Note: not completion accepting of the any following New Patients paperwork who and Initial are Screening
More informationClinical Policy: Olanzapine Long-Acting Injection (Zyprexa Relprevv) Reference Number: CP.PHAR.292 Effective Date: Last Review Date: 08.
Clinical Policy: (Zyprexa Relprevv) Reference Number: CP.PHAR.292 Effective Date: 12.01.16 Last Review Date: 08.18 Line of Business: Medicaid See Important Reminder at the end of this policy for important
More informationHOSPITAL BASED INPATIENT PSYCHIATRIC SERVICES (HBIPS) MEASURE SET
HOSPITAL BASED INPATIENT PSYCHIATRIC SERVICES (HBIPS) MEASURE SET Kathy Wonderly RN, MSEd, CPHQ Consultant Developed: February, 2013 Most recently revised: December 2018 The Psychiatric Measure Set CMS
More information#55 PRESCRIBING AND MONITORING PSYCHI RIC MEDICATIONS
- '_ ADMINISTRA TIVE/FISCAUCLINICAL/PHF POLICY AND PROCEDURES COUNTY OF SANTA BARBARA ALCOHOL, DRUG AND MENTAL HEAL TH SERVICES Section - QUALITY ASSURANCE Effective: 12/1/09 Policy- Director's Approval
More informationMedications: The Dark Side
Medications: The Dark Side Robert P. Smith, MD Potential Mechanisms of Drug Effects Metabolic effects Alterations of Immunologic factors in CNS Interference with synaptic transmission Excess dopaminergic
More informationAPPENDIX E COMMONLY PRESCRIBED MEDICATIONS BY CATEGORY BY BRAND (GENERIC)
APPENDIX E COMMONLY PRESCRIBED MEDICATIONS BY CATEGORY BY BRAND (GENERIC) Revised June 2005 Page E-1 Prescribed Medications by Category by Brand This is not an all-inclusive list ANTIPSYCHOTICS ANTIDEPRESSANTS
More informationALAMEDA COUNTY BEHAVIORAL HEALTH CARE SERVICES MEDICATION FORMULARY
ANTIDEPRESSANTS Serotonin Selective Reuptake Inhibitors citalopram 10, 20, 40 mg, 10 mg/5cc $ 0.40 No escitalopram 10, 20 mg $ 2.60 Yes fluoxetine 10, 20 mg, 20 mg/5 ml $ 0.40 Yes fluvoxamine 25, 50, 100
More informationMedically Accepted Indications for Pediatric Use of Psychotropic Medications by
Key: White Background: Medically Accepted Indication Yellow Backgroun: Medically Accepted Indication Status Not Ascertained Orange Background: Pediatric Indication cited, but not supported Red Background:
More informationKatee Kindler, PharmD, BCACP
Speaker Introduction Katee Kindler, PharmD, BCACP Current Practice: Clinical Pharmacy Specialist Ambulatory Care, St. Vincent Indianapolis Assistant Professor of Pharmacy Practice, Manchester University,
More informationDepression: Assessment and Treatment For Older Adults
Tool on Depression: Assessment and Treatment For Older Adults Based on: National Guidelines for Seniors Mental Health: the Assessment and Treatment of Depression Available on line: www.ccsmh.ca www.nicenet.ca
More informationUSF Health Psychiatry Clinic. New Patient Questionnaire Adult
USF Health Psychiatry Clinic New Patient Questionnaire Adult Please mail or fax the completed forms to the address/fax number on the bottom of this page. Completed forms must be received five (5) days
More informationAAA. add dan campbell artwork cats? Report #12 Changes in Medication Use over Time in Adolescents and Adults with Autism Spectrum Disorders
AAA Adolescents & Adults with Autism A Study of Family Caregiving add dan campbell artwork cats? Report #12 Changes in Medication Use over Time in Adolescents and Adults with Autism Spectrum Disorders
More informationNew Patient Questionnaire
4 Embarcadero Center, Suite 1400, San Francisco, CA 94111 (415) 926-7774 phone; (415) 591-7760 office@sanfranciscopsych.com New Patient Questionnaire Thank you for trusting San Francisco Psychiatry with
More informationDebra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist. HMS Training Webinar January 27, 2017
Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist HMS Training Webinar January 27, 2017 1 Describe nationwide prevalence and types of elderly dementia + define BPSD Define psychotropic
More informationTreatments for Alzheimer s Disease A Quick Guide for Patients and Caregivers
Treatments for Alzheimer s Disease A Quick Guide for Patients and Caregivers By Kelsey F. Lee, PharmD candidate 2011 Preceptor: Demetra Antimisiaris, PharmD University of Louisvlle Dept. Family Medicine
More informationThank you for choosing Pine Rest Christian Mental Health Services. We look forward to providing services to you.
Thank you for choosing Pine Rest Christian Mental Health Services. We look forward to providing services to you. In order to make the most of your first appointment, please come at least 30 minutes prior
More informationManagement of Delirium in Hospice Patients
Presentation Objectives Management of Delirium in Hospice Patients Lynn Williams, BSPharm Clinical Pharmacist Hospice Pharmacy Solutions Identify the clinical features of delirium Understand the underlying
More informationA Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer
A Brief Overview of Psychiatric Pharmacotherapy Joel V. Oberstar, M.D. Chief Executive Officer Disclosures Some medications discussed are not approved by the FDA for use in the population discussed/described.
More informationSUTTER PHYSICIANS ALLIANCE (SPA) 2800 L Street, 7 th Floor Sacramento, CA 95816
SUTTER PHYSICIANS ALLIANCE (SPA) 2800 L Street, 7 th Floor Sacramento, CA 95816 SPA PCP Treatment & Referral Guideline Managing Depression in Older Adults Developed March 1, 2003 Revised September 21,
More informationMental Health Intake Form
Current Symptoms Checklist: (check once for any symptoms present, twice for major symptoms) ( ) ( ) Depressed mood ( ) ( ) Racing thoughts ( ) ( ) Excessive worry ( ) ( ) Unable to enjoy activities ( )
More informationPATIENT FACE SHEET PATIENT NAME: PATIENT DOB: PATIENT PHONE #: INSURANCE: MEMBER ID: GROUP NUMBER: PATIENT ADDRESS
1 P a g e PATIENT FACE SHEET PATIENT NAME: PATIENT DOB: PATIENT PHONE #: INSURANCE: MEMBER ID: GROUP NUMBER: PATIENT ADDRESS PRIOR AUTHORIZATION #: (for office use only) INS. CONTACT NAME/ DIRECT NUMBER:
More informationNatural Medicines Food-Drug Interactions and Other Interesting Stuff
Natural Medicines Food-Drug Interactions and Other Interesting Stuff Homeopathy Like treats Like More dilute = More potent Potentization serial dilutions Forrest Batz, PharmD Assistant Professor of Pharmacy
More informationWhat Team Members Other Than Prescribers Need To Know About Antipsychotics
What Team Members Other Than Prescribers Need To Know About Antipsychotics The Care Transitions Network National Council for Behavioral Health Montefiore Medical Center Northwell Health New York State
More informationAntipsychotic Medication
Antipsychotic Medication Mary Knutson, RN 3-7-12 Mosby items and derived items 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 1 Clinical Uses of Antipsychotics Short-term: in severe depression and
More informationPsychiatric Illness. In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis
Psychiatric Illness In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis 12,000,000 children infants through 18 y/o nation wide 5,000,000 suffer severely Serious
More informationCENPATICO INTEGRATED CARE BEHAVIORAL HEALTH DRUG LIST BY DRUG NAME. Use Brand Only
ACAMPROSATE TABLET DELAYED RELEASE ALPHA-TOCOPHEROL CAPSULES ALPRAZOLAM CONCENTRATE 1 MG/ML ALPRAZOLAM ODT TABLET 0.25MG, 0.5MG, 1MG ALPRAZOLAM ODT TABLET 2MG ALPRAZOLAM SR TABLET 24-HOUR ALPRAZOLAM TABLET
More informationWhy Target Delirium for Surgical Quality Improvement?
Why Target Delirium for Surgical Quality Improvement? Tom Robinson MD FACS thomas.robinson@ucdenver.edu July 22, 2018 Disclosures Tom Robinson has no disclosures. Who Cares About the Brain? Acute Organ
More informationPROBE INITIAL ZERO/ DK: Please include any prescription medicines, even if you took them only once.
04/18/01 PHARMACOEPIDEMIOLOGY (PH) *PH1. The next questions are about your use of medicines. First, how many different kinds of prescription medicine have you taken during the past seven days? (IF NEC:
More informationNew Patient Information - Adolescent
Scanned Ages 12-17 Dear Parent: To help your clinician understand and help your child, please answer the questions on this form and bring it with you to your child s first appointment. Please print using
More informationMental Health Medications. National Institute of Mental Health. U.S. Department of HealtH and HUman ServiceS National Institutes of Health
Mental Health Medications National Institute of Mental Health U.S. Department of HealtH and HUman ServiceS National Institutes of Health Contents Mental Health Medications...1 What are psychiatric medications?...1
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: (Invega Sustenna, Invega Trinza) Reference Number: CP.PHAR.291 Effective Date: 12.01.16 Last Review Date: 08.18 Line of Business: Medicaid See Important Reminder at the end of this policy
More informationGeriatric Delirium: Translating Guidelines into Practice
Geriatric Delirium: Translating Guidelines into Practice Dr. Peter Chan, MD, FRCPC Geriatric and Consult-Liaison Psychiatrist Vancouver General Hospital Clinical Professor of Psychiatry University of British
More information2/12/2016. Drugs and Dementia in the Hospice Patient. Jim Joyner, Pharm.D., C.G.P. Director of Clinical Operations Outcome Resources
Drugs and Dementia in the Hospice Patient Jim Joyner, Pharm.D., C.G.P. Director of Clinical Operations Outcome Resources 1 Drug Therapy: Targeted at Symptoms Cognitive: Impaired abstract thinking Impaired
More informationPRACTICAL MANAGEMENT OF DEPRESSION IN OLDER ADULTS. Lee A. Jennings, MD MSHS Assistant Professor Division of Geriatrics, UCLA
CASE #1 PRACTICAL MANAGEMENT OF DEPRESSION IN OLDER ADULTS Lee A. Jennings, MD MSHS Assistant Professor Division of Geriatrics, UCLA OBJECTIVES Epidemiology Presentation in older adults Assessment Treatment
More informationNorthSTAR. Pharmacy Manual
NorthSTAR Pharmacy Manual Revised October, 2008 Table of I. Introduction II. III. IV. Antidepressants New Generation Antipsychotic Medications Mood Stabilizers V. ADHD Medications VI. Anxiolytics and Sedative-Hypnotics
More informationDepression among Older Adults. Prevalence & Intervention Strategies
Depression among Older Adults Prevalence & Intervention Strategies Definition Depression is a complex syndrome complex characterized by mood disturbance plus variety of cognitive, psychological, and vegetative
More informationSchedule FDA & literature based indications
Psychotropic Medication List Recommended dosages are intended to serve only as a guide for children. Recommended doses are literature based. Clinicians should consult package insert of medications for
More informationWelcome and thank you for choosing University of Florida Physicians!
DEPARTMENT OF PSYCHIATRY Tuesday, Division of March Child and 14, Adolescent 2017 Psychiatry 8491 NW 39 th Ave. Gainesville, FL 32606 Phone: 352-265-4357 Fax: 352-627-4163 Welcome and thank you for choosing
More informationPotentially Inappropriate Medication Use in Older Adults 2015 Latest Research
Home Resources Potentially Inappropriate Medication Use in Older Adults 2015 Resources Potentially Inappropriate Medication Use in Older Adults 2015 Latest Research Drugs and Categories of Drugs What these
More informationQuality ID #238 (NQF 0022): Use of High-Risk Medications in the Elderly National Quality Strategy Domain: Patient Safety
Quality ID #238 (NQF 0022): Use of High-Risk Medications in the Elderly National Quality Strategy Domain: Patient Safety 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process DESCRIPTION:
More informationRAI-MDS 2.0 ASSESSMENT GUIDE FOR USE BY CANADIAN SQLI NURSING HOMES AND NEWFOUNDLAND AND LABRADOR HOMES
RAI-MDS 2.0 ASSESSMENT GUIDE FOR USE BY CANADIAN SQLI NURSING HOMES AND NEWFOUNDLAND AND LABRADOR HOMES HOW TO USE THIS GUIDE: Use this guide alongside the RAI-MDS 2.0 Tracking Tool to track your target
More informationSupplement: Tables and Figures
Supplement: Tables and Figures Supplement Table 1. Baseline Characteristics by Study and Efavirenz Assignment Supplement Table 2. Baseline Psychoactive Medications by Efavirenz Assignment* Supplement Table
More informationHigh-risk medications in older adults drug alternative(s)
Antianxiety Analgesics Antihypertensive High-risk medications in older adults drug alternative(s) Guanabenz Guanfacine Methyldopa Reserpine (greater than 0.1 mg per day) High risk of adverse central nervous
More information8/15/14. Julie Wood, MD Southwestern Behavioral Healthcare & Mulberry Memory Clinic
Julie Wood, MD Southwestern Behavioral Healthcare & Mulberry Memory Clinic SILVER TSUNAMI DEPRESSION STATS DIAGNOSTIC CRITERIA ASSESSMENT OF GERIATRIC DEPRESSION RISK FACTORS TREATMENT OPTIONS FOR GERIATRIC
More informationPartners in Care Quick Reference Cards
Partners in Care Quick Reference Cards Supported by the Agency for Healthcare Research and Quality MR-1198/8-AHRQ R This project was funded by the Agency for Healthcare Research and Quality (AHRQ), formerly
More informationmed ed Copyright All rights reserved. No part of this publication can be reproduced without prior written consent of the authors.
med ed Dr. Andrea Murphy, Assistant Professor, School of Nursing, Dalhousie University; Research Associate, Sun Life Financial Chair in Adolescent Mental Health Dr. David Gardner, Associate Professor,
More informationMental Health Intake Form
38600 Van Dyke Ave., Suite 200 Sterling Heights, MI 48313 Phone: (586) 933-5395 Fax: (586) 935-0159 Mental Health Intake Form Please complete all information on this form and bring it to the first visit.
More informationU T I L I Z A T I O N E D I T S
I N D I A N A H E A L T H C O V E R A G E P R O G R A M S U T I L I Z A T I O N E D I T S A P R I L 1 9, 2 0 1 2 s for s Refer to Provider Bulletin BT200709 for additional information regarding the Mental
More informationThe clinical response to the same dose
Making sense of CYP2D6 and CYP1A2 genotype vs phenotype O. Greg Deardorff, PharmD, BCPP, Victoria Jenne, PharmD, MPH, BCPS, and Lauren Leonard, PharmD The clinical response to the same dose of a drug may
More informationResults from the REPOSI Study
Drugs Aging (2013) 30:103 112 DOI 10.1007/s40266-012-0044-x ORIGINAL RESEARCH ARTICLE Association of Anticholinergic Burden with Cognitive and Functional Status in a Cohort of Hospitalized Elderly: Comparison
More informationMedicine Related Falls Risk Assessment Tool (MRFRAT)
Medicine Related Falls Risk Assessment Tool (MRFRAT) The Medicine Related Falls Risk Assessment tool (MRFRAT) in Appendix 1 is designed to help identify patients at risk of falls due to their current medicine
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: (Abilify Maintena, Aristada, Aristada Initio) Reference Number: CP.PHAR.290 Effective Date: 12.01.16 Last Review Date: 08.18 Line of Business: Medicaid Coding Implications Revision Log
More informationUse Brand Only. Preferred Drug Status PRIOR AUTHORIZATION REQUIRED
Generic Drugs Are Over Brand Drugs Unless Specified As Brand ANTIDEPRESSANTS ALPHA-2 RECEPTOR ANTAGONIST ANTIDEPRESSANTS MIRTAZAPINE REMERON 30 30 MIRTAZAPINE REMERON SOLTAB 30 30 ISOCARBOXAZID TABLETS
More informationAnthony J. Caprio, MD, CMD, AGSF 1
Objectives 1) Discuss the dangers of polypharmacy 2) Review potentially inappropriate medications for older adults Doc, I think I am taking too many medications! 3) Develop strategies for prioritizing
More informationDo benzos, opioids, or strong anticholinergics cause delirium? Lisa Burry
Do benzos, opioids, or strong anticholinergics cause delirium? Lisa Burry Delirium in the ICU Occurs in up to 85% of MICU/SICU MV patients 20-50% of lower severity ICU patients develop delirium Hypoactive
More informationAntipsychotics and stroke risk
Integrating Sentinel into Routine Regulatory Drug Review: A Snapshot of the First Year Antipsychotics and stroke risk Lockwood G. Taylor, PhD, MPH Division of Epidemiology II Office of Pharmacovigilance
More informationPSYCHIATRIC HISTORY 6. Are you currently seeing a therapist? (Name & contact phone#)
Cool Springs Psychiatric Group PATIENT HISTORY Patient Name Date of Birth Date form completed: *Please arrive on time and bring this form completed to your appointment to avoid any delay in seeing the
More informationPsychotropic Medication Use in Dementia
Psychotropic Medication Use in Dementia Marie A DeWitt, MD Diplomate of the American Board of Psychiatry and Neurology, Specialization in Psychiatry & Subspecialization in Geriatric Psychiatry Staff Physician,
More informationAntidepressant Medication Strategies We ve Come a Long Way or Have We? Who Writes Prescriptions for Psychotropic Medications. Biological Psychiatry
Antidepressant Medication Strategies We ve Come a Long Way or Have We? Joe Wegmann, PD, LCSW The PharmaTherapist Joe@ThePharmaTherapist.com 504.587.9798 www.pharmatherapist.com Are you receiving our free
More informationMichael J. Bailey, M.D. OptumHealth Public Sector
Michael J. Bailey, M.D. OptumHealth Public Sector LIHP Quality Charter To ensure the quality of care delivered to enrollees in San Diego County Assistance Programs, such as County Medical Services (CMS)
More informationSchizophrenia and Related Psychotic Disorders
and Related Psychotic Disorders Anand K. Pandurangi, MD Professor & Chair, Div. of Inpatient Psychiatry Director, Program VCU Medical Center 1 Kraeplin 1896 Dementia Praecox. Single, Homogenous Disorder
More informationPatient History Form
Patient History Form Date: / / NAME: Last First Middle Birthdate: / / Age: Sex: F M Please read the following questions and answer to the best of your ability by placing a check mark in the appropriate
More informationPharmacy Benefit Management (PBM) Program FORMULARY/PRODUCT RESTRICTIONS
Workforce Safety & Insurance Revised Document Date: 07/21/2015 1600 E Century Ave Ste 1 PO Box 5585 Bismarck, ND 58506-5585 701.328.3800 1.800.777.5033 www.workforcesafety.com Pharmacy Benefit Management
More information4240 Blue Ridge Blvd., Suite 1000 Kansas City, MO (816) Patient Instruction
www.silversteineyecenters.com 4240 Blue Ridge Blvd., Suite 1000 Kansas City, MO 64133 (816) 358.3600 Patient Instruction CONSENT FORM FOR ALLERGY SKIN TESTING Skin Test: Skin tests are methods of testing
More informationNortriptyline vs amitriptyline in elderly
Nortriptyline vs amitriptyline in elderly Amitriptyline (Elavil ) vs other antidepressants - comparative analysis amitriptyline vs divalproate, amitriptyline vs trazodone. Learn what other patients are
More informationCENPATICO INTEGRATED CARE BEHAVIORAL HEALTH DRUG LIST BY DRUG CLASS
ANTIDEPRESSANTS ALPHA-2 RECEPTOR ANTAGONIST ANTIDEPRESSANTS MIRTAZAPINE ODT TABLETS 15 MG REMERON SOL 90 30 MIRTAZAPINE ODT TABLETS 30 MG REMERON SOL 45 30 MIRTAZAPINE ODT TABLETS 45 MG REMERON SOL 30
More information4/2/13 COMMON CLASSES OF MEDICATIONS. Child & Adolescent Behavioral Medicine & Medication Therapies. Behavioral Medicine & Medication Therapies
Child & Adolescent Behavioral Medicine & Medication Therapies Brian J Cowles, PharmD Associate Professor of Pharmacy Practice Albany College of Pharmacy & Health Sciences; Vermont Campus Behavioral Medicine
More informationMaking Sense of the Long Term Care Mega Rule: Unnecessary Drugs & Psychotropics. Session Objectives. January 2018
Making Sense of the Long Term Care Mega Rule: Unnecessary Drugs & Psychotropics Bridget McCrate Protus, PharmD, MLIS, BCGP, CDP Director of Drug Information Optum Hospice Pharmacy Services Session Objectives
More informationOBJECTIVES PSYCHOTROPIC MEDICATIONS WHAT IS PSYCHOTROPIC MEDICATION?
PSYCHOTROPIC MEDICATIONS Sally Davies, Ph.D., HSPP Licensed Psychologist OBJECTIVES 1. Identify psychotropic medications and the typical usages 2. Identify effective methods for the practical application
More information